Marcy A. Bliss
Marcy A. Bliss is the CEO of Wedgewood Pharmacy, the leading compounding pharmacy for animals in the US. She is responsible for all aspects of the pharmacy operation and for leading the delivery of extraordinary business results. In 2018 Wedgewood Pharmacy acquired Diamondback Drugs, based in Scottsdale, Arizona. Formerly the executive vice president of Business Operations and Marketing, Bliss began her career with Wedgewood Pharmacy in early 1999. Over the years, she assumed positions of increasing responsibility, many with a significant emphasis on pharmacy growth, the building of infrastructure, acquisitions, strategic partnerships, and regulatory compliance. She leads the company's public affairs and issues-management programs, and is frequently seen on Capitol Hill, protecting patient and prescriber access to compounded medication.
In addition to her role on the Board of Wedgewood Pharmacy, Marcy is a volunteer Chair of the Board of Trustees of The Appel Farm Arts & Music Center, and board member of many organizations including The New Jersey Business and Industry Association (NJBIA), IndeVets, and Together Women’s Health. Previously, Marcy served on the board of directors of the Tobin Foundation for the Visually Impaired (Wilmington, DE).
Bliss holds a B.S. degree in Business/Marketing and Management Studies from the University of Maryland. A life-long learner, she has continued her education at The Wharton School for Executive Education (University of Pennsylvania), the Hasso Plattner Institute of Design at Stanford University (California) as well as extensive leadership training from Gap International.
Wedgewood Pharmacy has won two awards from the NJBIA for Business Success (growth) and Employee Satisfaction. Bliss has been recognized by Marcom as the 2017 Healthcare Innovator of the Year, by NJBIA in 2018 as one of NJ’s 50 Most Powerful Women in Business, and by the Gloucester County Chamber of Commerce in 2019 as Businessperson of the Year.